NYSE American - Delayed Quote USD
NeurAxis, Inc. (NRXS)
2.2900
-0.0100
(-0.43%)
At close: June 13 at 4:00:00 PM EDT
2.2400
-0.05
(-2.18%)
After hours: June 13 at 7:50:54 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -0.2 | -0.18 | -0.88 | -0.18 |
Low Estimate | -0.2 | -0.18 | -0.88 | -0.18 |
High Estimate | -0.2 | -0.18 | -0.88 | -0.18 |
Year Ago EPS | -- | -- | -- | -0.88 |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | 967.25k | 1.2M | 4.61M | 11M |
Low Estimate | 967.25k | 1.2M | 4.61M | 11M |
High Estimate | 967.25k | 1.2M | 4.61M | 11M |
Year Ago Sales | -- | -- | -- | 4.61M |
Sales Growth (year/est) | -- | -- | -- | 138.46% |
Earnings History
Currency in USD | 12/31/2024 | 3/31/2025 |
---|---|---|
EPS Est. | -- | -0.24 |
EPS Actual | -0.21 | -0.33 |
Difference | -- | -0.09 |
Surprise % | -- | -37.50% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.2 | -0.18 | -0.88 | -0.18 |
7 Days Ago | -0.23 | -0.21 | -0.98 | -0.22 |
30 Days Ago | -0.25 | -0.24 | -0.98 | -0.51 |
60 Days Ago | -0.25 | -0.24 | -0.98 | -0.51 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | -- | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
NRXS | -- | -- | -- | 79.55% |
S&P 500 | 13.13% | 2.43% | 7.54% | 14.06% |
Related Tickers
PTIX Protagenic Therapeutics, Inc.
3.3200
-5.68%
ALZN Alzamend Neuro, Inc.
3.2400
+1.57%
PALI Palisade Bio, Inc.
0.6401
-7.23%
WINT Windtree Therapeutics, Inc.
0.5920
-1.99%
HCWB HCW Biologics Inc.
5.45
-0.91%
ELAB PMGC Holdings Inc.
2.0800
-4.15%
ABP Abpro Corporation
0.2150
-11.85%
PSTV Plus Therapeutics, Inc.
0.3140
-10.08%
SCNI Scinai Immunotherapeutics Ltd.
2.2200
-4.72%
PHIO Phio Pharmaceuticals Corp.
2.2700
-8.10%